Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats

被引:3
|
作者
Doubek, M
Mayer, J
Lauschova, I
Scheer, P
Krejcirova, L
Horky, D
Doubek, J
机构
[1] Univ Hosp, Dept Internal Med Haematol Oncol, Brno 62500, Czech Republic
[2] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic
[3] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Physiol & Pathophysiol, Brno, Czech Republic
关键词
amphotericin B colloidal dispersion; amphotericin B desoxycholate; nephrotoxicity; rat;
D O I
10.1111/j.1440-1797.2005.00339.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim: Amphotericin B (AmB) desoxycholate remains as one of the most efficacious agents currently available for the treatment of systemic fungal infections; however, amphotericin B colloidal dispersion (ABCD) has been developed because of AmB desoxycholate nephrotoxicity. The goal of our study was to compare the effect of administration of AmB desoxycholate and ABCD on renal functions and renal morphology in rats. Results: Amophotericin B desoxycholate as well as ABCD causes damage to renal tubuli and polyuria. Amophotericin desoxycholate causes considerably more severe damage to tubuli than ABCD, but the morphological damage to renal glomeruli is minimal in both formulas. In tubular cells, AmB desoxycholate causes severe damage to mitochondria, vacuolation of cytoplasm, and increased values of volume density of peroxisomes. Conclusion: None of these formulas causes a decrease in glomerular filtration in rats when animals are properly hydrated.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 50 条
  • [1] Amphotericin B desoxycholate and amphotericin B colloidal dispersion nephrotoxicity models in rats and their implication for hernatooncological patients
    Doubek, M
    Mayer, J
    Doubek, J
    Horky, D
    Scheer, P
    BLOOD, 2002, 100 (11) : 213B - 213B
  • [2] Ultrastructural morphometry of renal tubule epithelium in rats treated with conventional amphotericin B deoxycholate or amphotericin B colloidal dispersion
    Lauschová, I
    Krejcírová, L
    Horky, D
    Doubek, M
    Mayer, J
    Doubek, J
    ACTA VETERINARIA BRNO, 2004, 73 (02) : 165 - 169
  • [3] Nephrotoxicity of amphotericin B desoxycholate
    Girmenia, C
    Gentile, G
    Micozzi, A
    Martino, P
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) : 915 - 916
  • [4] AMPHOTERICIN B TOXICITY - CHANGES IN RENAL MORPHOLOGY
    HILL, GJ
    ANNALS OF INTERNAL MEDICINE, 1964, 61 (02) : 349 - +
  • [5] Renal sparing by amphotericin B colloidal dispersion: Clinical experience in 572 patients
    Gurwith, M
    Mamelok, R
    Pietrelli, L
    Du Mond, C
    CHEMOTHERAPY, 1999, 45 : 39 - 47
  • [6] Safety of amphotericin B colloidal dispersion
    Herbrecht, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (01) : 74 - 80
  • [7] Safety of amphotericin B colloidal dispersion
    R. Herbrecht
    European Journal of Clinical Microbiology and Infectious Diseases, 1997, 16 : 74 - 80
  • [8] Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species
    S. Perkhofer
    G. Blum
    C. Speth
    A. Mayr
    M. P. Dierich
    C. Lass-Flörl
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 413 - 417
  • [9] Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species
    Perkhofer, S.
    Blum, G.
    Speth, C.
    Mayr, A.
    Dierich, M. P.
    Lass-Floerl, C.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (06) : 413 - 417
  • [10] Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): Aerosol characteristics and in-vivo amphotericin B deposition in rats
    Ruijgrok, EJ
    Vulto, AG
    Van Etten, EWM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (06) : 619 - 627